Search

Zai Lab Ltd ADR

Aperta

SettoreSettore sanitario

24.23 -3.85

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

23.61

Massimo

25.54

Metriche Chiave

By Trading Economics

Entrata

191K

-51M

Vendite

6.7M

106M

EPS

-0.46

Margine di Profitto

-47.808

Dipendenti

1,784

EBITDA

-2.1M

-46M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+54.78% upside

Dividendi

By Acuity

Utili prossimi

5 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

892M

2.9B

Apertura precedente

28.08

Chiusura precedente

24.23

Notizie sul Sentiment di mercato

By Acuity

38%

62%

106 / 339 Classifica in Healthcare

Zai Lab Ltd ADR Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

9 set 2026, 23:51 UTC

News

Toll Brothers Inc. shares are lower in after-market trading, continuing a trend of declining performance amid broader market pressures and rising crude oil prices.

9 set 2026, 23:51 UTC

News

Lakeland Industries reported a fiscal Q2 net loss of $4.9 million and lower-than-expected sales, leading shares to decline in after-market trading.

9 set 2026, 23:51 UTC

News

Limoneira Co reported third-quarter results that missed expectations, with revenues falling to $43.8 million and shares trading lower in after-market hours.

9 set 2026, 23:51 UTC

Social Media
News

Lockheed Martin received $1.08 billion in defense contract modifications from the U.S. Department of Defense, boosting shares modestly higher during after-market hours.

9 set 2026, 23:41 UTC

News

Ovintiv Inc shares are higher in after-market hours following Stifel's Buy rating and $92.00 price target from analyst David Deckelbaum.

9 set 2026, 23:41 UTC

News

Chewy Inc shares fell in after-market trading following analyst downgrades and price target cuts from Jefferies and Evercore. The stock has declined for five consecutive sessions.

9 set 2026, 23:41 UTC

News

America's CAR-MART Inc shares are lower in after-market hours following disappointing Q2 results, with revenue down 57.1% and a non-GAAP loss of $6.65 per share.

9 set 2026, 23:36 UTC

News

DICK'S Sporting Goods is facing a class action lawsuit over alleged false statements regarding its business operations, contributing to a decline in after-market hours.

9 set 2026, 23:31 UTC

Social Media
News

Apple Inc. introduced new AirPods 5 and Apple Watch Series 12, enhancing audio and health features. Shares are trading higher in after-market hours.

9 set 2026, 23:26 UTC

News

Abbott Laboratories received U.S. FDA approval for its TactiFlex Duo ablation catheter. Shares are higher in after-market trading, reflecting a recovery from recent declines.

9 set 2026, 23:21 UTC

News

L3Harris Technologies shares are trading higher in after-market hours, recovering from three consecutive declines despite broader market pressures from rising U.S. Treasury yields.

9 set 2026, 23:21 UTC

News

Verizon shares are higher in after-market hours following a positive investor conference, where executives highlighted strong broadband growth and strategic cost-cutting measures.

9 set 2026, 23:16 UTC

News

Joby Aviation appoints Sergey Novikov as Principal Accounting Officer, effective September 2026. Shares are higher in after-market trading following this leadership change.

9 set 2026, 23:16 UTC

News

Dycom Industries shares are higher in after-market trading ahead of a meeting with KeyBanc on September 16, reflecting investor interest in strategic discussions.

9 set 2026, 23:11 UTC

News

Nasdaq Inc shares advanced modestly in after-market trading following three consecutive lower sessions, amid rising crude oil prices and inflation concerns impacting monetary policy.

9 set 2026, 23:06 UTC

News
Correlated Moves

Intuit Inc. filed an automatic mixed securities shelf, with shares trading lower in after-market hours, reflecting a broader decline and correlation with Adobe Inc.

9 set 2026, 23:06 UTC

News

Boeing Co advances in U.S. Army interceptor competition, shares trading higher in after-market hours. Only two firms have progressed in the selection process.

9 set 2026, 23:06 UTC

Social Media
News

Coca-Cola's CEO outlines a strategy focusing on digital advancements and balanced growth. Shares remain roughly flat in after-market trading since Wednesday's close.

9 set 2026, 23:06 UTC

News

Stifel analyst David Deckelbaum resumed coverage on APA Corp with a Buy rating. Shares are higher in after-market hours, closing at $43.55.

9 set 2026, 23:06 UTC

News

Conagra Brands Inc. shares rose in after-market trading after Slim Jim set a Guinness World Record for the longest meat snack stick at 429 feet.

9 set 2026, 23:06 UTC

News

Simon Property Group priced $800 million in senior notes to repay debt. Shares are trading higher in after-market hours following the announcement.

9 set 2026, 23:06 UTC

News
Correlated Moves

ADP data shows an increase of 12,000 jobs, influencing USD/CZK, which is trading higher. The pair remains within its one-month trading range.

9 set 2026, 23:06 UTC

News

Permian Resources shares rise in after-market hours following a Buy rating from Stifel analyst David Deckelbaum and a target price of $30.00.

9 set 2026, 23:06 UTC

Social Media
News

Meta Platforms Inc shares are lower in after-market hours following the departure of key AI researcher Andrew Tulloch and concerns over tax breaks for data centers.

9 set 2026, 23:06 UTC

News

Beam Therapeutics shares are trading higher in after-market hours following a presentation at Citigroup's Biopharma Summit, highlighting advancements in its pipeline.

9 set 2026, 23:02 UTC

Social Media
News

American Eagle Outfitters shares fell in after-hours trading following a second-quarter earnings report that included a $134.08 million net income and a cautious sales outlook.

9 set 2026, 23:01 UTC

Event
Social Media
News

Cooper Companies reported a net income of $432.8 million but missed revenue expectations, leading to a decline in after-hours trading. Fourth-quarter guidance was lowered.

9 set 2026, 23:01 UTC

News

Wix.com Ltd shares decline in after-market hours amid legal challenges from two class action lawsuits over misleading statements about its AI offerings and costs.

9 set 2026, 23:01 UTC

News

T-Mobile US participated in Citi's TMT Conference, where CFO Peter Osvaldik announced his retirement. Shares are higher in after-market trading.

9 set 2026, 23:01 UTC

Social Media
News

Adobe shares declined in after-market hours amid concerns over OpenAI's advertising policy affecting its product promotion. The stock remains below its 20-day moving average.

Confronto tra pari

Modifica del prezzo

Zai Lab Ltd ADR Previsione

Obiettivo di Prezzo

By TipRanks

54.78% in crescita

Previsioni per 12 mesi

Media 39.33 USD  54.78%

Alto 45 USD

Basso 36 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Zai Lab Ltd ADR - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

3 ratings

3

Acquista

0

Mantieni

0

Vendi

Sentiment

By Acuity

106 / 339 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.
help-icon Live chat